Mesothelin Is a Malignant Factor and Therapeutic Vaccine Target for Pancreatic Cancer

Pancreas - United States
doi 10.1097/01.mpa.0000297731.91864.2c
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy